TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
STVN

Stevanato Group SpA

Healthcare · Medical Instruments & Supplies

20.20$ +1.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Stevanato Group SpA (STVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 302 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Income Statement STVN
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
136 162 157 207 193 204 215 233 212 234 245 292 238 255 271 321 236 260 278 331 257 280 303 343 274 302 1,222
97 113 110 148 127 140 151 160 145 160 168 192 162 176 189 219 174 192 203 232 187 201 215 237 198 215 866
40 49 47 59 65 64 63 73 67 75 78 100 76 79 83 102 62 68 74 98 70 79 89 106 75 87 356
3.9 3.8 4.7 4.9 5.8 6.9 7.4 12 7.7 8.5 7.6 11 8.6 8.4 8.7 10 11 8.7 6.6 5.6 5.9 6.0 7.6 5.7 5.8 6.2 25
14 15 16 14 14 6.0 25 17 18 22 20 25 22 23 20 24 22 23 22 25 25 25 24 26 23 24 97
24 22 25 21 22 16 35 30 30 31 30 37 36 34 32 38 37 40 33 31 35 37 36 40 36 48 160
15 27 23 38 43 48 28 43 38 44 48 63 41 45 51 64 25 28 41 67 35 41 53 66 39 39 197
1.3 1.6 2.2 1.7 1.3 1.3 1.0 1.5 0.9 1.0 1.0 1.1 1.0 0.7 1.1 1.5 1.5 0.8 1.6 3.0 1.4 1.7 1.8 4.6 1.2 2.0 9.5
11 28 22 36 42 48 22 54 36 41 46 64 36 44 50 59 26 29 41 65 35 39 49 65 39 38 192
3.6 7.1 5.1 1.9 5.1 13 3.8 9.1 8.5 11 9.8 15 7.8 10 13 14 6.9 8.5 11 16 8.6 9.4 13 18 11 15 57
7.3 21 17 34 37 34 19 45 28 31 36 48 28 34 38 45 19 21 30 48 27 30 36 47 28 23 134
25 42 37 53 56 63 38 49 52 58 64 82 55 64 72 80 48 51 103 87 57 62 73 94 65 40 272

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?